Literature DB >> 12438334

Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice.

Donatella Pietrella1, Rosanna Mazzolla, Patrizia Lupo, Lucia Pitzurra, Maria Jesus Gomez, Robert Cherniak, Anna Vecchiarelli.   

Abstract

We previously demonstrated that mannoprotein (MP) from Cryptococcus neoformans (CnMP) stimulates interleukin-12 production by human monocytes, thus fostering a T-helper type 1 (Th1) protective anticryptococcal response. In this paper we show that CnMP was also able to induce a Candida albicans-directed protective Th1 response. This was demonstrated for mice immunized with CnMP by induction of a delayed-type hypersensitivity (DTH) reaction to C. albicans MP (CaMP) as well as induction of gamma interferon production by CD4(+) and CD8(+) splenic T cells stimulated in vitro with CaMP. CnMP-immunized mice were also partially protected from lethal systemic challenge with C. albicans, as shown by prolonged median survival times and decreased fungal burden in the kidney. Much evidence supports the validity of these cross-reactive and functional Th1 responses: (i) a non-cross-reactive C. albicans antigen, such as enolase, did not produce a DTH response to CaMP; (ii) passive adoptive transfer of T cells primed with CnMP induced a DTH reaction; (iii) C. neoformans extract elicited a DTH response to CaMP; and (iv) a monoclonal antibody (7H6) directed against a major and immunodominant T-cell-stimulatory 65-kDa MP (MP65) of C. albicans also recognized discrete 100-kDa constituents of C. neoformans extracts, as well as secretory constituents of the fungus. These results suggest the presence of common Th1 antigenic determinants in the mannoproteic material of C. neoformans and C. albicans epitopes, which should be considered in devising common strategies for immunoprophylactic or immunotherapeutic control of the fungi.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438334      PMCID: PMC132998          DOI: 10.1128/IAI.70.12.6621-6627.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans.

Authors:  S H Turner; R Cherniak; E Reiss
Journal:  Carbohydr Res       Date:  1984-02-15       Impact factor: 2.104

3.  Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans.

Authors:  A Torosantucci; C Palma; M Boccanera; C M Ausiello; G C Spagnoli; A Cassone
Journal:  J Gen Microbiol       Date:  1990-11

4.  Covalent association of beta-1,3-glucan with beta-1,6-glucosylated mannoproteins in cell walls of Candida albicans.

Authors:  J C Kapteyn; R C Montijn; G J Dijkgraaf; H Van den Ende; F M Klis
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

5.  A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.

Authors:  A Mencacci; A Torosantucci; R Spaccapelo; L Romani; F Bistoni; A Cassone
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Galactoxylomannans of Cryptococcus neoformans.

Authors:  P G James; R Cherniak
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  Identification of a 65-kDa mannoprotein as a main target of human cell-mediated immune response to Candida albicans.

Authors:  A Torosantucci; C Bromuro; M J Gomez; C M Ausiello; F Urbani; A Cassone
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

8.  Identification of a mannoprotein fraction from Candida albicans that enhances human polymorphonuclear leukocyte (PMNL) functions and stimulates lactoferrin in PMNL inhibition of candidal growth.

Authors:  C Palma; D Serbousek; A Torosantucci; A Cassone; J Y Djeu
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

9.  Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects.

Authors:  I Quinti; C Palma; E C Guerra; M J Gomez; I Mezzaroma; F Aiuti; A Cassone
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

10.  Influence of cryptococcal antigens on cell-mediated immunity.

Authors:  J W Murphy
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug
View more
  11 in total

Review 1.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

2.  A multifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections.

Authors:  Brice Enjalbert; Anna Rachini; Govindsamy Vediyappan; Donatella Pietrella; Roberta Spaccapelo; Anna Vecchiarelli; Alistair J P Brown; Christophe d'Enfert
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

3.  Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation.

Authors:  Donatella Pietrella; Cristina Corbucci; Stefano Perito; Giovanni Bistoni; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.

Authors:  Magdia De Jesus; André Moraes Nicola; Siu-Kei Chow; Ian R Lee; Shuhua Nong; Charles A Specht; Stuart M Levitz; Arturo Casadevall
Journal:  Virulence       Date:  2010-11-01       Impact factor: 5.882

5.  Protective efficacy of antigenic fractions in mouse models of cryptococcosis.

Authors:  Michael K Mansour; Lauren E Yauch; James B Rottman; Stuart M Levitz
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 6.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

7.  A Candida albicans mannoprotein deprived of its mannan moiety is efficiently taken up and processed by human dendritic cells and induces T-cell activation without stimulating proinflammatory cytokine production.

Authors:  Donatella Pietrella; Patrizia Lupo; Anna Rachini; Silvia Sandini; Alessandra Ciervo; Stefano Perito; Francesco Bistoni; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

8.  New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges.

Authors:  Anna Vecchiarelli; Eva Pericolini; Elena Gabrielli; Donatella Pietrella
Journal:  Front Microbiol       Date:  2012-08-13       Impact factor: 5.640

9.  Lymphocyte transformation assay for C neoformans antigen is not reliable for detecting cellular impairment in patients with neurocryptococcosis.

Authors:  Katya C Rocha; Cinthia Pinhal; Sônia Cavalcanti; Monica S M Vidal; Matheus Toscano; Dewton Moraes-Vasconcelos; Alberto J S Duarte; Fernando L A Fonseca; Luiz Carlos de Abreu; Vitor E Valenti; Anete S G Grumach
Journal:  BMC Infect Dis       Date:  2012-10-30       Impact factor: 3.090

10.  Protective immunity against cryptococcus neoformans infection.

Authors:  Joel Schop
Journal:  Mcgill J Med       Date:  2007-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.